Neuronetics (STIM) Net Income towards Common Stockholders Growth (5y) (2022 - 2026)
Neuronetics (STIM) Net Income towards Common Stockholders Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn |
| 10 | Neuronetics | 225.60 Mn | 206.17 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.08% |
| Mar 31, 2026 | 12.09% |
| Dec 31, 2025 | -15.16% |
| Sep 30, 2025 | -8.74% |
| Jun 30, 2025 | -18.32% |
| Mar 31, 2025 | -2.15% |
| Dec 31, 2024 | -12.06% |
| Sep 30, 2024 | 8.94% |
| Jun 30, 2024 | 15.30% |
| Mar 31, 2024 | -1.72% |
| Dec 31, 2023 | 1.57% |
| Sep 30, 2023 | 35.06% |
| Jun 30, 2023 | 35.12% |
| Mar 31, 2023 | -15.09% |
| Dec 31, 2022 | -12.16% |
| Sep 30, 2022 | -19.23% |
| Jun 30, 2022 | -27.52% |
| Mar 31, 2022 | -27.47% |